Hyperkalaemia has been demonstrated to occur with the administration of both high and standard dosages of trimethoprim. The recognition of this disorder of potassium homeostasis prompted …

The authors present a case of Trimethoprim-sulfamethoxazole-induced hyperkalemia in a patient with normal renal function. While toxicity of this drug has been reported in patients with renal …

Trimethoprim-sulfamethoxazole (TMP-SMX), also known as co-trimoxazole, is a combination of two antimicrobial agents that act synergistically against a wide variety of bacteria. Although …

Aug 15, 1993 · Results: Humans: Trimethoprim increased the serum potassium concentration by 0.6 mmol/L (95% Cl, 0.29 to 0.95 mmol/L) despite normal adrenocortical function and …

Trimethoprim–sulfamethoxazole can influence kidney function in several ways, which can result in hyperkalemia and hyponatremia, among other kidney effects. Hyperkalemia This is a …

Feb 8, 2011 · Pharmacists should closely monitor patients who take trimethoprim and other drugs that increase serum potassium. Trimethoprim-Induced Hyperkalemia. Trimethoprim …

Jan 10, 2011 · Trimethoprim-sulfamethoxazole (TMP-SMX) is an antibiotic used for a variety of infections, and it may cause hyperkalemia by blocking amiloride-sensitive sodium channels in …

Jun 28, 2010 · Compared with amoxicillin, the use of trimethoprim-sulfamethoxazole was associated with a nearly 7-fold increased risk of hyperkalemia-associated hospitalization …

BRASH (bradycardia, renal failure, atrioventricular-node blockers, shock, and hyperkalemia) syndrome is a recently coined term for a condition that describes the severe bradycardia and …

The hyperkalemia resolved spontaneously on discontinuation of TMP­ SMX therapy, suggesting that this electrolyte abnormality is related to altered renal tubular secretion of potassium as a …